#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3829382	Functional	Attenuation of methicillin-resistant Staphylococcus aureus Mu 50 virulence in BALB/c mouse systemic infection model assessed as decrease in bacterial survival in liver at 200 mg/kg, ip administered every 12 hrs for 108 hrs followed by bacterial challenge after first 12 hrs of compound dosing measured 5 days post infection	Staphylococcus aureus	2	ALA3826951	organism-based format	Scientific Literature
2.	ALA3830152	Functional	Attenuation of methicillin-resistant Staphylococcus aureus USA400 MW2 virulence in BALB/c mouse systemic infection model assessed as decrease in bacterial burden in liver at 200 mg/kg, ip administered every 12 hrs for 108 hrs followed by bacterial challenge after first 12 hrs of compound dosing measured 5 days post infection	Staphylococcus aureus	2	ALA3826951	organism-based format	Scientific Literature
3.	ALA3830153	Functional	Attenuation of methicillin-resistant Staphylococcus aureus USA400 MW2 virulence in BALB/c mouse systemic infection model assessed as decrease in bacterial burden in liver at 50 mg/kg, ip administered every 12 hrs for 108 hrs followed by bacterial challenge after first 12 hrs of compound dosing measured 5 days post infection	Staphylococcus aureus	2	ALA3826951	organism-based format	Scientific Literature
4.	ALA3830156	Functional	Attenuation of methicillin-resistant Staphylococcus aureus Mu 50 virulence in BALB/c mouse systemic infection model assessed as decrease in bacterial survival in liver at 50 mg/kg, ip administered every 12 hrs for 108 hrs followed by bacterial challenge after first 12 hrs of compound dosing measured 5 days post infection	Staphylococcus aureus	2	ALA3826951	organism-based format	Scientific Literature
5.	ALA3830157	Functional	Attenuation of methicillin-resistant Staphylococcus aureus Mu 50 virulence in BALB/c mouse systemic infection model assessed as decrease in bacterial survival in kidney at 200 mg/kg, ip administered every 12 hrs for 108 hrs followed by bacterial challenge after first 12 hrs of compound dosing measured 5 days post infection	Staphylococcus aureus	2	ALA3826951	organism-based format	Scientific Literature
6.	ALA3830158	Functional	Attenuation of methicillin-resistant Staphylococcus aureus Mu 50 virulence in BALB/c mouse systemic infection model assessed as decrease in bacterial survival in kidney at 50 mg/kg, ip administered every 12 hrs for 108 hrs followed by bacterial challenge after first 12 hrs of compound dosing measured 5 days post infection	Staphylococcus aureus	2	ALA3826951	organism-based format	Scientific Literature
7.	ALA3830163	Binding	Inhibition of Staphylococcus aureus ATCC 27659 full length His-tagged dehydrosqualene synthase expressed in Escherichia coli BL21 (DE3) cells assessed as reduction in staphyloxanthin pigment formation after 72 hrs by spectrophotometric analysis	Staphylococcus aureus	1	ALA3826951	cell-based format	Scientific Literature
8.	ALA808970	Binding	Inhibitory activity against rat liver microsomal squalene synthase was determined using [3H]FPP as radioligand		25	ALA1129470	assay format	Scientific Literature
9.	ALA784697	Functional	Compound was tested for inhibition of cholesterol biosynthesis in rats by intravenous (iv) dosing.	Rattus norvegicus	7	ALA1129471	organism-based format	Scientific Literature
10.	ALA880206	Functional	Compound was tested for inhibition of cholesterol biosynthesis in rats by oral dosing (po).	Rattus norvegicus	14	ALA1129471	organism-based format	Scientific Literature
11.	ALA779633	Functional	In vivo effective dose against Cholesterol Biosynthesis in rats by oral administration	Rattus norvegicus	1	ALA1129470	organism-based format	Scientific Literature
12.	ALA781991	Functional	In vivo intravenous effective dose against cholesterol biosynthesis in rats	Rattus norvegicus	12	ALA1129470	organism-based format	Scientific Literature
13.	ALA941163	Binding	Inhibition of Staphylococcus aureus dehydrosqualene synthase expressed in Escherichia coli BL21 (DE3) cells by continuous spectrophotometric assay	Staphylococcus aureus	38	ALA1140905	cell-based format	Scientific Literature
14.	ALA941164	Functional	Inhibition of staphyloxanthin biosynthesis in Staphylococcus aureus Pig1 isolate after 72 hrs	Staphylococcus aureus	38	ALA1140905	organism-based format	Scientific Literature
15.	ALA941165	Binding	Inhibition of human recombinant squalene synthase expressed in Escherichia coli BL21 (DE3) cells assessed as formation of 1,10-dioic acid metabolite by liquid scintillation	Homo sapiens	38	ALA1140905	cell-based format	Scientific Literature
16.	ALA4008294	Binding	Inhibition of Staphylococcus aureus ATCC 27659 histidine-tagged full length CrtM expressed in Escherichia coli BL21(DE3) cells assessed as decrease in staphyloxanthin formation after 30 mins by continous spectrophotometric method	Staphylococcus aureus	1	ALA4007400	cell-based format	Scientific Literature
17.	ALA4027795	Binding	Inhibition of CrtM in Staphylococcus aureus assessed as reduction in staphyloxanthin levels after 72 hrs by spectrophotometric method	Staphylococcus aureus	1	ALA4024779	single protein format	Scientific Literature